BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 205 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $393,319 | -33.5% | 16,787 | -6.2% | 0.00% | -50.0% |
| Q1 2024 | $591,152 | +21.4% | 17,892 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $487,020 | -18.2% | 17,892 | -27.8% | 0.00% | -33.3% |
| Q3 2023 | $595,598 | -30.5% | 24,765 | -7.8% | 0.00% | 0.0% |
| Q2 2023 | $857,289 | +24.2% | 26,849 | +19.1% | 0.00% | 0.0% |
| Q1 2023 | $690,420 | -29.3% | 22,548 | -9.7% | 0.00% | -40.0% |
| Q4 2022 | $976,107 | +18.0% | 24,958 | +43.8% | 0.01% | +25.0% |
| Q3 2022 | $827,000 | +29.4% | 17,357 | +5.2% | 0.00% | +33.3% |
| Q2 2022 | $639,000 | -9.4% | 16,496 | +34.1% | 0.00% | 0.0% |
| Q1 2022 | $705,000 | +9.3% | 12,297 | +51.9% | 0.00% | +50.0% |
| Q4 2021 | $645,000 | -9.7% | 8,097 | -1.3% | 0.00% | -33.3% |
| Q3 2021 | $714,000 | -32.4% | 8,203 | 0.0% | 0.00% | -40.0% |
| Q2 2021 | $1,056,000 | +56.7% | 8,203 | -2.6% | 0.01% | +66.7% |
| Q1 2021 | $674,000 | – | 8,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |